Satoshi Tanida
8Patents
2h-index
21Co-inventors
47Inventor score
Filing activity: Nov 27, 2009 → Aug 30, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10858356B2 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | Emerging Cross-Sectional Technologies | 7 | Active |
| US11814381B2 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | Emerging Cross-Sectional Technologies | 2 | Active |
| US12187724B2 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | Emerging Cross-Sectional Technologies | 0 | Active |
| US8420668B2 | 1-(2H)-isoquinolone derivative | Human Necessities | 0 | Active |
| US12331050B2 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | Emerging Cross-Sectional Technologies | 0 | Active |
| US12410168B2 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | Emerging Cross-Sectional Technologies | 0 | Active |
| USRE50455E1 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | General | 0 | Active |
| US12331049B2 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.